Pages that link to "Q44028222"

The following pages link to Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats (Q44028222):

Displaying 24 items.

• Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis (Q28483086) (← links)
• Procainamide Inhibits DNA Methylation and Alleviates Multiple Organ Dysfunction in Rats with Endotoxic Shock (Q28554338) (← links)
• Ameliorative influence of Urtica dioica L against cisplatin-induced toxicity in mice bearing Ehrlich ascites carcinoma (Q34632527) (← links)
• In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach (Q35722244) (← links)
• Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients (Q35769777) (← links)
• Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis. (Q35975350) (← links)
• The influence of very low doses of Cisplatin on tumor cell proliferation in vitro and on some hematological and enzymatic parameters of healthy rats (Q37118341) (← links)
• Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy. (Q37441359) (← links)
• Hepatoprotective effect of Zataria Multiflora Boisson cisplatin-induced oxidative stress in male rat (Q37655763) (← links)
• Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues. (Q38436491) (← links)
• Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks (Q39054155) (← links)
• Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis (Q39418413) (← links)
• Sorghum [Sorghum bicolor (L.) Moench] leaf sheath dye protects against cisplatin-induced hepatotoxicity and oxidative stress in rats (Q42110501) (← links)
• Extremely low-frequency magnetic field enhances the therapeutic efficacy of low-dose cisplatin in the treatment of Ehrlich carcinoma (Q43240652) (← links)
• Effects of BSO and L-cysteine on drug-induced cytotoxicity in primary cell cultures: drug-, cell type-, and species-specific difference (Q45102463) (← links)
• The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats (Q45207968) (← links)
• The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester (Q46573794) (← links)
• Production of high specific activity (195m) Pt-cisplatinum at South African Nuclear Energy Corporation for Phase 0 clinical trials in healthy individual subjects (Q46636418) (← links)
• Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats (Q46717226) (← links)
• Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats (Q46970952) (← links)
• Tirapazamine has no Effect on Hepatotoxicity of Cisplatin and 5-fluorouracil but Interacts with Doxorubicin Leading to Side Changes in Redox Equilibrium. (Q53144349) (← links)
• Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats. (Q53274636) (← links)
• The protective effect of pomegranate extract against cisplatin toxicity in rat liver and kidney tissue. (Q53393698) (← links)
• Mechanisms of drug combinations: interaction and network perspectives (Q83265745) (← links)